KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 103 filers reported holding KEROS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,251,000 | +36.2% | 272,498 | 0.0% | 1.80% | +4.6% |
| Q2 2022 | $7,529,000 | -65.1% | 272,498 | -31.3% | 1.72% | -66.2% |
| Q1 2022 | $21,584,000 | +26.0% | 396,911 | +35.5% | 5.10% | -9.7% |
| Q4 2021 | $17,134,000 | +190.0% | 292,833 | +96.1% | 5.65% | +163.0% |
| Q3 2021 | $5,908,000 | -6.8% | 149,333 | 0.0% | 2.15% | -17.6% |
| Q2 2021 | $6,342,000 | -5.8% | 149,333 | +36.6% | 2.61% | -8.1% |
| Q1 2021 | $6,729,000 | – | 109,333 | – | 2.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |